SIERRA ONCOLOGY INC's ticker is SRRA and the CUSIP is 82640U107. A total of 63 filers reported holding SIERRA ONCOLOGY INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $924,000 | -38.5% | 2,366,707 | -11.7% | 0.51% | -32.2% |
| Q2 2019 | $1,502,000 | -64.3% | 2,681,618 | +9.1% | 0.76% | -58.8% |
| Q1 2019 | $4,203,000 | +24.7% | 2,457,683 | -3.8% | 1.84% | +5.7% |
| Q4 2018 | $3,371,000 | -27.1% | 2,553,943 | -6.1% | 1.74% | -32.5% |
| Q3 2018 | $4,624,000 | -13.5% | 2,720,089 | +50.6% | 2.58% | -34.2% |
| Q2 2018 | $5,347,000 | +1.8% | 1,806,562 | -28.8% | 3.92% | +18.9% |
| Q1 2018 | $5,255,000 | – | 2,538,525 | – | 3.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 8,112,121 | $10,708,000 | 2.76% |
| New Leaf Venture Partners, L.L.C. | 5,020,446 | $6,627,000 | 1.82% |
| Prosight Management, LP | 2,553,943 | $3,371,000 | 1.74% |
| Abingworth LLP | 1,444,445 | $1,892,000 | 1.72% |
| Broadfin Capital, LLC | 4,880,327 | $6,442,000 | 0.85% |
| MANGROVE PARTNERS IM, LLC | 3,688,609 | $4,869,000 | 0.65% |
| Vivo Capital, LLC | 2,438,270 | $3,219,000 | 0.41% |
| PA Capital LLC | 138,752 | $183,000 | 0.19% |
| 683 Capital Management, LLC | 2,173,620 | $2,869,000 | 0.17% |
| ARMISTICE CAPITAL, LLC | 1,600,000 | $2,112,000 | 0.16% |